Screener
Vir Biotechnology, Inc. VIR Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| Grant revenue | $11K-94.0% | $12K-99.0% | $310K-71.7% | $305K-85.4% | $183K-91.4% | |
| License and collaboration revenue | $238.94M+48,370% | -$41K+41.4% | —— | —— | -$495K-103% | |
| Other revenue | $0-100% | $0-100% | —— | —— | $1.53M+161% |
FAQ
- How does Vir Biotechnology, Inc. break its business down?
- Vir Biotechnology, Inc. (VIR) reports total revenues by product across 3 parts — Grant revenue, License and collaboration revenue and Other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Vir Biotechnology, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Vir Biotechnology, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
